The Daily Northwestern

FDA details potential plan to grant accelerated approval to Duchenne treatment

Rebecca Savransky, Campus Editor

April 22, 2014

The Food and Drug Administration outlined a possible pathway that would grant accelerated approval to a drug with the potential to treat Duchenne muscular dystrophy, the disease Dance Marathon raised more than $1.3 million to fu...